FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

3527011000001100: Dexamethasone sodium metasulphobenzoate (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    14875901000001110 Dexamethasone sodium metasulphobenzoate (substance) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    14876001000001118 Dexamethasone sodium metasulphobenzoate en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    75318101000001110 Dexamethasone sodium metasulfobenzoate en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Dexamethasone sodium metasulphobenzoate Is a Dexamethasone false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Generic Sofradex eye/ear drops Has active ingredient False Dexamethasone sodium metasulphobenzoate Inferred relationship Existential restriction modifier
    Sofradex eye/ear drops (Florizel Ltd) Has active ingredient False Dexamethasone sodium metasulphobenzoate Inferred relationship Existential restriction modifier
    Generic Sofradex eye/ear drops 10 ml Has active ingredient False Dexamethasone sodium metasulphobenzoate Inferred relationship Existential restriction modifier
    Sofradex eye/ear drops (Florizel Ltd) 10 ml Has active ingredient False Dexamethasone sodium metasulphobenzoate Inferred relationship Existential restriction modifier
    Generic Sofradex eye/ear drops Has specific active ingredient False Dexamethasone sodium metasulphobenzoate Inferred relationship Existential restriction modifier
    Sofradex eye/ear drops (Florizel Ltd) 10 ml Has specific active ingredient False Dexamethasone sodium metasulphobenzoate Inferred relationship Existential restriction modifier
    Sofradex eye/ear drops (Florizel Ltd) Has specific active ingredient False Dexamethasone sodium metasulphobenzoate Inferred relationship Existential restriction modifier
    Generic Sofradex eye/ear drops 10 ml Has specific active ingredient False Dexamethasone sodium metasulphobenzoate Inferred relationship Existential restriction modifier
    Generic Sofradex eye/ear drops Has specific active ingredient False Dexamethasone sodium metasulphobenzoate Inferred relationship Existential restriction modifier
    Sofradex eye/ear drops (Florizel Ltd) 10 ml Has specific active ingredient False Dexamethasone sodium metasulphobenzoate Inferred relationship Existential restriction modifier
    Sofradex eye/ear drops (Florizel Ltd) Has specific active ingredient False Dexamethasone sodium metasulphobenzoate Inferred relationship Existential restriction modifier
    Generic Sofradex eye/ear drops 10 ml Has specific active ingredient False Dexamethasone sodium metasulphobenzoate Inferred relationship Existential restriction modifier
    Sofradex ear/eye drops (Mawdsley-Brooks & Company Ltd) Has specific active ingredient False Dexamethasone sodium metasulphobenzoate Inferred relationship Existential restriction modifier
    Sofradex ear/eye drops (Mawdsley-Brooks & Company Ltd) 10 ml Has specific active ingredient False Dexamethasone sodium metasulphobenzoate Inferred relationship Existential restriction modifier
    Generic Sofradex ear/eye drops 8 ml Has specific active ingredient False Dexamethasone sodium metasulphobenzoate Inferred relationship Existential restriction modifier
    Sofradex ear/eye drops (Sanofi) 8 ml Has specific active ingredient False Dexamethasone sodium metasulphobenzoate Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start